Publication:
Prognostic Impact of let-7e MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) Study

dc.contributor.authorFernandez-Serra, Antonio
dc.contributor.authorMoura, David S.
dc.contributor.authorSanchez-Izquierdo, María Dolores
dc.contributor.authorCalabuig-Fariñas, Silvia
dc.contributor.authorLopez-Alvarez, Maria
dc.contributor.authorMartínez-Martínez, Andrea
dc.contributor.authorCarrasco-Garcia, Irene
dc.contributor.authorRamírez-Calvo, Marta
dc.contributor.authorBlanco-Alcaina, Elena
dc.contributor.authorLópez-Reig, Raquel
dc.contributor.authorObrador-Hevia, Antonia
dc.contributor.authorAlemany, Regina
dc.contributor.authorGutierrez, Antonio
dc.contributor.authorHindi, Nadia
dc.contributor.authorPoveda, Andres
dc.contributor.authorLopez-Guerrero, Jose A.
dc.contributor.authorMartin-Broto, Javier
dc.contributor.authoraffiliation[Fernandez-Serra,A; Martínez-Martínez,A; Ramírez-Calvo,M; López-Reig,R; Lopez-Guerrero,JA] Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología, Valencia, Spain. [Moura,DS; Lopez-Alvarez,M; Carrasco-Garcia,I; Blanco-Alcaina,E; Hindi,N; Martin-Broto,J] Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain. [Sanchez-Izquierdo,MD] Instituto de Investigación Sanitaria La Fe, Valencia, Spain. [Calabuig-Fariñas,S] Molecular Oncology Laboratory, Fundación Investigación, Hospital General Universitario de Valencia, Valencia, Spain. [Calabuig-Fariñas,S] Centro de Investigación Biomédica en Red de Cáncer (CIBEROnc), Madrid, Spain. [Calabuig-Fariñas,S] Department of Pathology, Universitat de València, Valencia, Spain. [Carrasco-Garcia,I; Hindi,N; Martin-Broto,J] Medical Oncology Department, University Hospital Virgen del Rocio, Sevilla, Spain. [Obrador-Hevia,A] Group of Advanced Therapies and Biomarkers in Clinical Oncology, Institut d’Investigació Sanitària de les Illes Balears (IdISBa-IUNICS), Palma de Mallorca, Spain. [Obrador-Hevia,A] Sequencing Unit, University Hospital Son Espases, Palma de Mallorca, Spain. [Alemany,R] Department of Biology, Balearic Islands University, Palma de Mallorca, Spain. [Gutierrez,A] Hematology Department, University Hospital Son Espases, Mallorca, Spain. [Poveda,A] Medical Oncology Department, Fundación Instituto Valenciano de Oncología, Valencia, Spain. [Lopez-Guerrero,JA] Department of Basic Medical Sciences, School of Medicine, Catholic University of Valencia ‘San Vicente Martir’, Valencia, Spain.
dc.contributor.funderThe project was funded by the Instituto de Salud Carlos III (ISCIII (Carlos III Health Institute))-Fondo Europeo de Desarrollo Regional; FEDER (European Regional Development Fund (ERDF)), through a public competitive call (project reference PI15/01254; principal investigator Javier Martín Broto) and by the Consejería de la Salud-Junta de Andalucia–(Health Council–Regional Government of Andalusia)-Proyectos de investigación coordinados 2016, through a competitive public call (project reference PC-0537-2016-0537; principal investigator Nadia Hindi).
dc.date.accessioned2023-01-12T09:59:46Z
dc.date.available2023-01-12T09:59:46Z
dc.date.issued2020-10-14
dc.description.abstractMicroRNAs (miRNAs) are small non-coding RNAs that negatively regulate gene expression at the post-transcriptional level, and they have been described as being associated with tumor prognosis. Here, miRNA profiling was planned to explore new molecular prognostic biomarkers in localized intestinal high-risk GIST. Paraffin tumor blocks of 14 and 86 patients were used in the discovery and expansion sets, respectively. GeneChip miRNA v3.0 was employed to identify the miRNAs differentially expressed between relapsed and non-relapsed patient samples, which were validated in the expansion set, by qRT-PCR. RT2 Profiler PCR Array was used for the screening of let-7e targets. Expression levels were correlated with relapse-free survival and overall survival. In the discovery set, 39 miRNAs were significantly deregulated, let-7e and miR-550 being the most underexpressed and overexpressed miRNAs in the relapsed group, respectively. In the expansion set, the underexpression of let-7e or the overexpression of 4 of its target genes (ACVR1B, CASP3, COL3A1, and COL5A2) were statistically associated with worse relapse-free survival. The expression of let-7e and 4 of its target genes are potential prognostic biomarkers in high-risk localized intestinal GIST. The expression of these genes is a potential molecular tool useful for a more accurate prognosis in this subset of GIST patients.es_ES
dc.description.versionYeses_ES
dc.identifier.citationFernandez-Serra A, Moura DS, Sanchez-Izquierdo MD, Calabuig-Fariñas S, Lopez-Alvarez M, Martínez-Martínez A, et al. Prognostic Impact of let-7e MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) Study. Cancers. 2020 Oct 14;12(10):2979es_ES
dc.identifier.doi10.3390/cancers12102979es_ES
dc.identifier.essn2072-6694
dc.identifier.pmcPMC7602387
dc.identifier.pmid33066614es_ES
dc.identifier.urihttp://hdl.handle.net/10668/4579
dc.journal.titleCancers
dc.language.isoen
dc.page.number18 p.
dc.publisherMDPIes_ES
dc.relation.publisherversionhttps://www.mdpi.com/2072-6694/12/10/2979es_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectGISTes_ES
dc.subjectlet-7ees_ES
dc.subjectPrognostic biomarkerses_ES
dc.subjectCaspase-3es_ES
dc.subjectmiR-550es_ES
dc.subjectGastrointestinal stromal tumorses_ES
dc.subjectMicroRNAes_ES
dc.subjectPrognosises_ES
dc.subjectTarget geneses_ES
dc.subjectTumores del estroma gastrointestinales_ES
dc.subjectMicroARNses_ES
dc.subjectPronósticoes_ES
dc.subjectBiomarcadoreses_ES
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Nucleic Acids, Nucleotides, and Nucleosides::Antisense Elements (Genetics)::RNA, Antisense::MicroRNAses_ES
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosises_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Hydrolases::Peptide Hydrolases::Endopeptidases::Cysteine Endopeptidases::Caspases::Caspases, Effector::Caspase 3es_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Paraffines_ES
dc.subject.meshMedical Subject Headings::Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Neoplasms, Connective Tissue::Gastrointestinal Stromal Tumorses_ES
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::Gene Expressiones_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Biological Factors::Biological Markerses_ES
dc.titlePrognostic Impact of let-7e MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) Studyes_ES
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 5 of 7
Loading...
Thumbnail Image
Name:
FernandezSerra_Prognostic.pdf
Size:
2.51 MB
Format:
Adobe Portable Document Format
Description:
Artículo publicado
Loading...
Thumbnail Image
Name:
FernandezSerra_Prognostic_Figura1.tif
Size:
583.88 KB
Format:
Tag Image File Format
Description:
Material suplementario
Loading...
Thumbnail Image
Name:
FernandezSerra_Prognostic_Figura2.tif
Size:
913.2 KB
Format:
Tag Image File Format
Description:
Material suplementario
Loading...
Thumbnail Image
Name:
FernandezSerra_Prognostic_Figura3.tif
Size:
1.39 MB
Format:
Tag Image File Format
Description:
Material suplementario
No Thumbnail Available
Name:
FernandezSerra_Prognostic_Tabla1.docx
Size:
12.25 KB
Format:
Microsoft Word XML
Description:
Material suplementario